Appears On
Episode Appearances
Moonshots with Peter Diamandis · Apr 28, 2026
David Sinclair: The GLP-1 Side Effect No One Talks About, What AI Found in His Lab, and Reversing Blindness | Q&A EP #251
“Co-researcher and spouse influencing David's integration of mindfulness, meditation, and environmental optimization into longevity protocols”
GLP-1 drug side effects and safety monitoringAI-driven drug design and molecular screeningCellular reprogramming (OSK therapy)
View AnalysisMoonshots with Peter Diamandis · Apr 27, 2026
David Sinclair on the Longevity Pill, Age Reversal Timelines, and Updated Protocols | EP #250
“David's spouse; inspired lifestyle changes (veganism, meditation, alcohol cessation) and senolytic drug research”
Epigenetic Reprogramming Technology (OSK genes, Yamanaka factors)Gene Therapy Delivery Systems (AAV, lipid nanoparticles, chemical small molecules)Small-Molecule Drug Development for Longevity
View Analysis